Vaborbactam
Vabomere, Vaborem (vaborbactam) is a small molecule pharmaceutical. Vaborbactam was first approved as Vabomere on 2017-08-29. It is used to treat bacterial infections in the USA. It has been approved in Europe to treat bacteremia, bacterial infections, pneumonia, respiratory tract infections, and urinary tract infections amongst others. Vabomere's patents are valid until 2031-08-29 (FDA).
| Trade Name | Vaborem |
|---|---|
| Common Name | Vaborbactam |
| Indication | bacteremia, bacterial infections, pneumonia, respiratory tract infections, urinary tract infections, ventilator-associated pneumonia |
| Drug Class | Beta-lactamase inhibitors |
